| mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
| mRNA |
QL-XII-47 |
GDSC1000 |
pan-cancer |
AAC |
0.0056 |
0.9 |
| mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.9 |
| mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.0091 |
0.9 |
| mRNA |
WZ-1-84 |
GDSC1000 |
pan-cancer |
AAC |
-0.0089 |
0.9 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0048 |
0.9 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
STF-62247 |
GDSC1000 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
BRD9876:MK-1775 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.9 |